Investors
We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.
Second Quarter 2025
Second quarter 2025 results were reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation was followed by a Q&A session.
Press Releases
September 11, 2025
Press Release: Sanofi’s SAR402663 earns fast track designation in the US for neovascular age-related macular degeneration
September 10, 2025
Media Update: ECTRIMS: Sanofi showcases patient focus across multiple sclerosis
September 10, 2025
Press Release: Tzield approved in China as first disease-modifying therapy for adult and pediatric patients with stage 2 type 1 diabetes
Upcoming Events
3Sep
2025
4Sep
2025
Wells Fargo Healthcare Conference
08:00 - 17:00 EDT (Boston)
Conferences
9Sep
2025
30th Consecutive Year of Dividend Increase
Environment, Social, Governance
As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.
Contact Our Investor Relations Team
For general inquiries
Please contact the switchboard, +33 (0)1 53 77 40 00